COVID-19 cases are falling again in the US. Whether they will rise again depends on how Americans behave and what the unpredictable virus does next.
Author: Karen Weintraub, USA TODAY
‘I was a carefree kid’
Since COVID, Rose Lehane Tureen as had one non-stop headache. The 13-year-old says doctors were initially dismissive of her pain.
Pfizer’s vaccine is FDA-approved for adults, but it’s still a ‘no-no’ to vaccinate kids under 12
Children under 12 have not yet been approved to receive any COVID-19 vaccine, despite the FDA’s approval of the Pfizer-BioNTech shot on Monday.
FDA authorizes COVID-19 vaccine boosters for the immunocompromised
People with suppressed immune systems may not have gotten adequate protection from initial doses of COVID vaccine and may need a booster, FDA says.
They volunteered for COVID-19 vaccine trials. Months later, they’re still ‘in limbo’ awaiting FDA authorization.
About 50,000 Americans volunteered for Novavax and AstraZeneca COVID vaccine trials but the companies haven’t asked the FDA they be cleared for use.
Delta variant substantially more contagious than other variants, CDC presentation warns
Evidence is mounting about the dangers of the delta variant and how mask-wearing is essential to bring it under control, according to a CDC memo.
Breakthrough COVID infections after vaccination can lead to long-haul symptoms, Israeli study shows
The findings raise questions about the coronavirus vaccines’ protection and suggest that even vaccinated people could experience long-term symptoms.
COVID booster shot ‘would be helpful’ for immunocompromised people, advisory committee recommends
People who are severely immune-compromised should consider getting a third dose of a COVID-19 vaccine, a federal advisory committee said on Thursday.
The fourth wave of COVID-19 cases is here. Will we escape the UK’s fate? It’s too soon to know.
COVID-19 may not be as deadly in this new wave, because older people are largely vaccinated and younger people are less likely to die.
Pfizer COVID-19 booster shot extends strong protection, company says, vaccine being updated to target Delta variant
Pfizer and BioNTech say their COVID booster provides extended protection and are updating the vaccine to target the highly contagious Delta variant.